Neuralgia Drugs Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Prevalence of Trigeminal Neuralgia
- Increasing Incidence Rate of Diabetes Around the World
Challenges
- Poor Efficacy of Several Available Neuralgia Drugs
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Neuralgia Drugs Market size is poised to grow at over 6.3% CAGR during the forecast period i.e., between 2025-2037.
The market growth is impelled by growing prevalence of trigeminal neuralgia and increasing incidence rate of diabetes around the world.
Asia Pacific industry is likely to hold largest revenue share by 2037, on the back of increasing occurrence of diabetes and rising elderly population in the region.
The major players in the market are Pfizer, Inc., Novartis AG, Biogen Inc., Cadila Healthcare Limited, Lundbeck Pharmaceuticals LLC, and others.
